News & Insights

27th May 2020

Generic Pharmaceutical Market: M&A Activity

The global generic pharmaceutical market has experienced robust deal activity over the last 18 months to the end of 2019 but is now contending with the COVID-19 crisis which has had an immediate and unprecedented impact on health systems. It is yet unclear what the long-term general impact on generic drug usage will be, but […]

20th May 2020

Moderna Coronavirus vaccine trial shows promising early results and the markets move positively

Every week is a roller coaster in the current COVID-19 environment. Most of us spend Sunday evenings preparing ourselves for the upcoming week and hoping for some positive developments on the healthcare, economy, or financial markets’ fronts. Luckily, on Monday, May 18th, Moderna’s coronavirus vaccine trial shed some light at the end of the tunnel […]

15th May 2020

Virtual deal-making – a new normal for the M&A world

Towards a brave new “all-In” virtual deal-making world Once obligatory rituals of the investment process, the “gut check” in-person meeting between a buyer and the operator-sellers are now being replaced with video conference interviews and virtual facility tours (and the detailed physical inspection of the workplace and core scientific R&D facilities). In this paper, we […]

14th May 2020

Webinar: Private equity and the future of healthcare investment

3pm-4pm (BST - UK), 10am-11am (ET - NY)
7th May 2020

Resilience in uncertain times – The Bulletin: Issue 73

Resilience in uncertain times The Coronavirus pandemic is first and foremost, a human tragedy. Resilience is a key coping skill at home, and also an imperative trait for business leaders to practice in order to remain positive, be prepared and keep moving forward so that when the dust settles, they’re able to return businesses to […]

4th May 2020

Private Equity: Insights and Outlook

Private equity funding has been a driving force behind deal activity and growth in our sectors in recent years, and despite COVID-19 the private equity capital available is at record levels. Structural change will always create opportunity as well as challenges, and private equity is well placed to help businesses emerge strongly and take advantage […]

4th May 2020

Investor insights: Maurice Hernandez, Principal, Accel-KKR

We recently caught up with Maurice Hernandez, Principal at Accel-KKR. Founded in the US in 2000, Accel-KKR is a leading Silicon Valley-based technology focused private equity firm, with offices in Menlo Park, Atlanta, and London, UK. Maurice shared his views on how PE is responding to the current climate and his key advice for entrepreneurs. […]

4th May 2020

Investor Insights: Christian Hamilton, Managing Partner, Tenzing

We recently caught up with Christian Hamilton, Managing Partner at Tenzing, an independent private equity (PE) investor that invests in high organic growth UK SMEs valued up to £75m. How are you supporting your portfolio companies at this time? We’ve been providing operational support with certain issues which are common across our portfolio companies. For […]

29th April 2020

Forced adoption accelerates growth in uncertain times for the technology sector

Everything has changed … yet many things will stay the same So much has changed in a few short weeks: health fears for family, friends, and colleagues; living with the constraints of social distancing; and dealing with significant short-term economic dislocation arising from lock downs. And yet … so much is similar, in many ways […]


We add value by understanding our sectors inside-out, and we release regular industry research and reports on key trends in the technology and healthcare sectors. Fill out the form to start receiving alerts when we publish new content or to follow our latest deals, upcoming events and company updates.

  • This field is for validation purposes and should be left unchanged.